Optimizing Care Closer to Home

“We believe high-quality speciality testing, like treatment, should be close to where a patient resides.”

– Dr. Gang Song, Founder

Leadership Team

Gang Song

Founder and Executive Chairman

Dr. Gang Song is the co-founder and founding CEO of Pillar Biosciences, where he co-invented the SLIMamp® technology and led the company from early research to the first multi-cancer CDx NGS kit to receive PMA approval by FDA. He currently serves as Executive Chairman of the Board at Pillar Biosciences.

Zhaohui Wang, Ph.D.

Co-founder and Chief Scientific Officer

Dr. Zhaohui Wang co-founded Pillar Biosciences, and co-invented SLIMamp technology. Previously, she held positions of increasing responsibility at LabCorp (previously Genzyme Genetics) and IQuum (subsequently acquired by Roche Molecular Diagnostics). Dr. Wang received her Ph.D. in Cellular and Molecular Biology from the University of Massachusetts, Amherst.

Dan Harma

Chief Commercial Officer

Mr. Dan Harma is the Chief Commercial Officer of Pillar Biosciences. He has more than 30 years of experience in the medical device industry, notably in in-vitro diagnostics, molecular diagnostics, and hematology markets. Prior to joining Pillar Biosciences, he served as Chief Commercial Officer at NeuMoDxTM where he led the commercial team and assisted in transitioning the business from research and development stage to full commercialization. Previously, he held multiple roles at Abbott Laboratories, Inc., in both the Diagnostics and Molecular divisions. His positions included oversight of product marketing, sales leadership, and commercial development. Mr. Harma received his MBA from Loyola University and his BBA in Marketing from the University of Wisconsin-Whitewater.


Board of Directors

Gang Song – Chairman of the Board


Simone Song – Director

Founder and Senior Partner, ORI Capital

Dr. Guoqiang Wang – Director

General Manager, Jiangsu Bioperfectus Technologies Co., Ltd.

Shawn Liu – Director

Chairman of the Board, China Biotech Services Holdings Limited

Scientific Advisory Board

Siraj Ali, MD, Ph.D.

VP of Clinical Development, EQRx Inc.

Cheng-Zhong Zhang, Ph.D.

Co-Founder, Pillar. Professor, Harvard Medical Shool

Marcia Eisenberg, Ph.D.

Chief Scientific Officer, Sr. VP, LabCorp

Timothy Springer, Ph.D.

Professor, Harvard Medical School

Paul M. Waring, MBBS, Ph.D., FRCPA, FRCPath, FHGSA, FFSc(RCPA)

Executive Director, Translational Pathology, AstraZeneca

Pillar Biosciences Inc.

9 Strathmore Rd., Natick MA, 01760